Modi Naturals FY26 Net Profit Jumps 62% to ₹50.3 Cr

4 min read     Updated on 20 May 2026, 05:15 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Modi Naturals Limited reported a 62.1% increase in consolidated net profit to ₹5028.35 lakh for FY26, with revenue from operations rising 8.5% to ₹71918.32 lakh. Q4 net profit surged 141% year-on-year to ₹1967.35 lakh, driven by strong performance across the Branded, Bulk, and Ethanol segments. The company commissioned Phase 2 of its ethanol expansion, increasing capacity to 282 KLPD, and provided FY27 revenue guidance of ₹950 crores. The board appointed a new statutory auditor and approved a shift in the registered office.

powered bylight_fuzz_icon
39942099

*this image is generated using AI for illustrative purposes only.

Modi Naturals Limited has announced its audited financial results for the quarter and year ended March 31, 2026. The company reported a consolidated net profit of ₹5028.35 lakh for FY26, marking a significant increase of 62.1% from ₹3102.57 lakh in the previous year. Revenue from operations for the year stood at ₹71918.32 lakh, compared to ₹66291.28 lakh in FY25. The results were reviewed by the Audit Committee and approved by the Board of Directors at its meeting held on May 13, 2026. Additionally, the company has uploaded the transcript of its earnings conference call held on May 14, 2026, on its website.

Financial Performance

The table below summarises the key consolidated financial metrics for the year ended March 31, 2026:

Parameter: Year Ended 31/03/2026 (₹ Lakhs) Year Ended 31/03/2025 (₹ Lakhs)
Revenue from Operations: 71918.32 66291.28
Total Income: 72016.72 66412.02
Total Expenses: 66148.91 62642.78
Profit for the Period: 5028.35 3102.57
Basic EPS (₹): 38.01 23.25

The standalone net profit for FY26 was ₹1001.41 lakh, with revenue from operations at ₹38183.15 lakh and basic EPS of ₹7.68.

Q4 Performance Highlights

Modi Naturals delivered a strong quarter, with key profitability metrics showing marked improvement on a year-on-year basis. The following table captures the Q4 consolidated performance highlights:

Metric: Q4 FY26 Q4 FY25
Revenue from Operations (₹ Lakhs): 24307.51 18989.50
Total Income (₹ Lakhs): 24328.26 19003.65
Net Profit (₹ Lakhs): 1967.35 816.08
Total Segment EBITDA (₹ Lakhs): 3037.72 1696.86
Basic EPS (₹): 15.00 6.05

The consolidated EBITDA margin for Q4 FY26 improved to 10.1% from 8.48% in Q4 FY25, reflecting enhanced operational efficiency. An exceptional item of ₹485.57 lakh, representing an insurance claim received by the subsidiary on account of loss of profit due to business interruption from a machinery breakdown in FY 2023-24, was recognised during the year.

Segment Performance

The company operates across three consolidated segments: Branded, Bulk, and Ethanol. The following table presents the segment-wise revenue and EBITDA for the year ended March 31, 2026:

Segment: Revenue FY26 (₹ Lakhs) Revenue FY25 (₹ Lakhs) EBITDA FY26 (₹ Lakhs) EBITDA FY25 (₹ Lakhs)
Branded: 18354.19 17781.35 1519.94 1505.86
Bulk: 19828.97 15859.87 259.67 170.20
Ethanol: 33735.17 32650.06 6346.79 4288.01
Total: 71918.32 66291.28 8126.40 5964.07

The Ethanol segment contributed the maximum revenue of ₹33735.17 lakh for the year, followed by Bulk at ₹19828.97 lakh and Branded at ₹18354.19 lakh. The standalone entity operates across two segments — Branded and Bulk — with combined revenue from operations of ₹38183.16 lakh for FY26.

Balance Sheet Highlights

The consolidated balance sheet as at March 31, 2026 reflects significant asset growth, primarily driven by capital investment in the Ethanol segment. Key balance sheet metrics are presented below:

Parameter: As at 31/03/2026 (₹ Lakhs) As at 31/03/2025 (₹ Lakhs)
Total Assets: 40661.45 32978.05
Total Equity: 17213.62 12155.41
Non-Current Borrowings: 12035.32 7077.83
Current Borrowings: 4086.08 7800.26
Cash and Cash Equivalents: 182.58 27.77

Net cash from operating activities for the year stood at ₹6105.80 lakh, compared to ₹4879.42 lakh in the previous year, while net cash used in investing activities was ₹7194.30 lakh, reflecting the significant capital expenditure of ₹8009.47 lakh on property, plant and equipment.

Management Commentary and Outlook

During the earnings conference call, management highlighted the successful commissioning of Phase 2 of the ethanol expansion, increasing capacity from 130 KL to 282 kiloliters per day. The company achieved FY26 guidance across revenue, EBITDA, and PAT. For FY27, the company provided a conservative revenue guidance of ₹950 crores, factoring in about 50% capacity utilization of the expansion. Management stated that with full capacity utilization, consolidated revenue could cross ₹1,100 crores.

The company does not envisage any large capex for FY27, except for an investment of up to ₹20 crores in a value addition project in the byproduct stream of the ethanol division. Working capital days improved to 62 days as of March 31, 2026, from 66 days in the previous year. Return on capital employed improved to 19.9% in FY26 from 18.3% in FY25.

Auditor Changes and Registered Office Shift

The board accepted the resignation of M/s Doogar & Associates (FRN: 000561N), Chartered Accountants, effective May 13, 2026. M/s B. CHHAWCHARIA & CO. (FRN: 305123E), Chartered Accountants, New Delhi, was appointed to fill the casual vacancy with effect from May 13, 2026, subject to shareholder approval. The board also approved a proposal to shift the registered office of the company from 405, Deepali Building, 92, Nehru Place, New Delhi-110019 to its corporate office at D-54, 2nd Floor, Okhla Industrial Area, Phase I, New Delhi-110020.

Historical Stock Returns for Modi Naturals

1 Day5 Days1 Month6 Months1 Year5 Years
-3.96%-10.92%+13.04%+11.45%+11.45%+11.45%

With ethanol capacity expanded to 282 KL/day and only 50% utilization factored into FY27 guidance, what key demand or regulatory factors could accelerate full capacity utilization and push revenue beyond ₹1,100 crores?

How might changes in India's ethanol blending policy or government procurement prices impact Modi Naturals' Ethanol segment margins, which already contribute the lion's share of EBITDA?

Given the sharp rise in non-current borrowings from ₹7,077 lakh to ₹12,035 lakh following Phase 2 capex, how sustainable is the company's debt servicing capacity if ethanol realization prices face downward pressure?

Modi Naturals Replaces Statutory Auditor, Appoints M/s B. CHHAWCHARIA & CO. Effective May 13, 2026

3 min read     Updated on 14 May 2026, 03:47 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Modi Naturals Limited announced a statutory auditor change on May 13, 2026, accepting the resignation of M/s Doogar & Associates (FRN: 000561N), who cited increased workload commitments after completing the audit for the year ended March 31, 2026. The Board appointed M/s B. CHHAWCHARIA & CO. (FRN: 305123E) as successor auditor, effective May 13, 2026, subject to shareholder approval, also noting the firm's existing role as auditor of material subsidiary Modi Biotech Private Limited.

powered bylight_fuzz_icon
40255968

*this image is generated using AI for illustrative purposes only.

Modi Naturals Limited announced a change in its statutory auditors on May 13, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board of Directors, at its meeting held on the same date, noted and accepted the resignation of M/s Doogar & Associates (FRN: 000561N), Chartered Accountants, New Delhi, and approved the appointment of a successor auditor to fill the resulting casual vacancy. The disclosure was made in accordance with Regulation 30 read with Schedule III of the SEBI Listing Regulations, 2015, and SEBI Master Circular No. Ho/49/14/14(7)2025-CFD-POD2/I/3762/2026, last updated on January 30, 2026.

Resignation of M/s Doogar & Associates

M/s Doogar & Associates had been appointed as the Statutory Auditors of Modi Naturals Limited pursuant to a shareholders' resolution dated September 30, 2023, for a term of 5 (five) consecutive years from the conclusion of the 49th Annual General Meeting till the conclusion of the 54th Annual General Meeting of the Company. The firm tendered its resignation effective May 13, 2026, citing increased demands from several new assignments that required substantial time and resources, which made it unable to continue dedicating the necessary attention and diligence to fulfil its responsibilities as statutory auditor.

Prior to its resignation, M/s Doogar & Associates completed the audit of the Company's Standalone and Consolidated financial statements and financial results for the year ended March 31, 2026, with audit reports dated May 13, 2026. The Audit Committee and Board members placed on record their appreciation for the firm's contribution to the Company's audit processes and standards. Key details of the resignation are summarised below:

Parameter: Details
Auditor Name: M/s Doogar & Associates (FRN: 000561N), Chartered Accountants, New Delhi
Reason for Resignation: Increased commitments from new assignments requiring substantial time and resources
Effective Date of Resignation: May 13, 2026
Date of Original Appointment: September 30, 2023
Original Term: 5 consecutive years — 49th AGM to 54th AGM
Last Audit Report Submitted: Standalone and Consolidated financial statements for the year ended March 31, 2026, dated May 13, 2026
Any Concerns / Audit Evidence Issues: Not Applicable

Appointment of M/s B. CHHAWCHARIA & CO.

Pursuant to Section 139 and other applicable provisions of the Companies Act, 2013, the Board of Directors, based on the recommendation of the Audit Committee and subject to approval of shareholders at the ensuing General Meeting, approved the appointment of M/s B. CHHAWCHARIA & CO. (FRN: 305123E), Chartered Accountants, as the Statutory Auditors of the Company with effect from May 13, 2026, to fill the casual vacancy caused by the resignation of M/s Doogar & Associates. The appointment is also noted to align with the fact that M/s B. CHHAWCHARIA & CO. is acting as the Statutory Auditor of Modi Biotech Private Limited, a material subsidiary of the Company, which is expected to ensure better alignment, consistency in audit processes, and operational synergies across the Group.

Key details of the new appointment are as follows:

Parameter: Details
Auditor Name: M/s B. CHHAWCHARIA & CO. (FRN: 305123E), Chartered Accountants
Reason for Appointment: To fill casual vacancy caused by resignation of M/s Doogar & Associates
Effective Date of Appointment: May 13, 2026
Subject To: Approval of shareholders at the ensuing General Meeting
Also Auditor Of: Modi Biotech Private Limited (material subsidiary)

Brief Profile of M/s B. CHHAWCHARIA & CO.

M/s B. Chhawchharia & Co. (BCCO) is a firm of practising Chartered Accountants providing services to domestic and international clients. The firm was established in the year 1966 by Late Basudeo Chhawchharia, who qualified as a Chartered Accountant from the Institute of Chartered Accountants of England and Wales in 1949 and was previously associated with M/s K N Gutgutia & Co. and M/s Gutgutia & Co. Since its establishment, the firm has expanded by adding partners, people, and new offices.

Regulatory Compliance

M/s B. CHHAWCHARIA & CO. certified its eligibility for appointment, confirming that:

  • It is not disqualified for appointment under the Companies Act, 2013, the Chartered Accountants Act, 1949, and applicable rules or regulations
  • The proposed appointment is as per the term provided under the Companies Act, 2013
  • The proposed appointment is within the limits laid down under the Companies Act, 2013
  • There are no proceedings pending against the firm or any partner with respect to professional matters of conduct

The disclosure was signed by Rajan Kumar Singh, Company Secretary & Compliance Officer of Modi Naturals Limited, on May 13, 2026.

Historical Stock Returns for Modi Naturals

1 Day5 Days1 Month6 Months1 Year5 Years
-3.96%-10.92%+13.04%+11.45%+11.45%+11.45%

How might the consolidation of audit responsibilities under M/s B. CHHAWCHARIA & CO. for both Modi Naturals and its material subsidiary Modi Biotech impact the quality and independence of financial oversight across the group?

Will shareholders raise any concerns about auditor independence at the ensuing General Meeting, given that the new auditor already serves Modi Naturals' material subsidiary?

Could the mid-term resignation of M/s Doogar & Associates signal broader capacity constraints in India's mid-tier audit firm ecosystem, and how might this affect other listed companies relying on similar firms?

More News on Modi Naturals

1 Year Returns:+11.45%